Our finding showing the correlation between IRF4 and SDC1 expression in MM cell lines may also explain the poor response of CD138 low patients to lenalidomide, which may contribute to poor prognosis, although only a small number of heterogeneously treated cases were analyzed. The gene discussed is SDC1; the disease is Miyoshi myopathy.